Back to top

Reorganization Agreement

Agreement and Plan of Merger

Reorganization Agreement | Document Parties: WORLDWIDE BIOTECH &| PHARMACEUTICAL CO | Yangling Daiying Biotech & Pharmaceutical Group Co., Ltd  | Hunan Ze An Pharmaceutical Co., Ltd You are currently viewing:
This Agreement and Plan of Merger involves

WORLDWIDE BIOTECH &| PHARMACEUTICAL CO | Yangling Daiying Biotech & Pharmaceutical Group Co., Ltd | Hunan Ze An Pharmaceutical Co., Ltd

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: Reorganization Agreement
Date: 4/6/2007
Industry: Food Processing     Sector: Consumer/Non-Cyclical

Reorganization Agreement, Parties: worldwide biotech &, pharmaceutical co , yangling daiying biotech & pharmaceutical group co.  ltd  , hunan ze an pharmaceutical co.  ltd
50 of the Top 250 law firms use our Products every day

EXHIBIT 10.2

 

Reorganization Agreement

 

January 19, 2006

 

This Reorganization Agreement is entered between Yangling Daiying Biotech & Pharmaceutical Group Co., Ltd (Yangling) and Hunan Ze An Pharmaceutical Co., Ltd (used to be named “Hunan Jin Jin Pharmaceutical Co., Ltd)(Ze An Pharmaceuticals) and its shareholders Zhongyu Lu, Aibin Chen and Weiliang Wu (Shareholders of Ze An Pharmaceuticals).

 

Yangling Daiying Biotech & Pharmaceutical Group Co., Ltd (Yangling), a corporation registered at Shaanxi Province, located at #10 Tai Cheng South Rd., Yangling High-tech Demonstration Zone, Shaanxi, P.R. China. The legal representative of Yangling is Wenxia Guo.

 

Hunan Ze An Pharmaceutical Co., Ltd (Ze An Pharmaceuticals), a company registered at Hunan Province, located at An Xiang Industrial Park, An Xian County, Hunan, P.R. China. The legal representative of Ze An Pharmaceuticals is: Zhongyu Lu.

 

In order to optimize company’s resources, promote the cross-province development, satisfy the requirements of the market, Yangling and Ze An Pharmaceuticals would like to reorganize subject to terms and conditions hereunder after carefully considering the advantages of the two parties:

 

1.  

Yangling and Ze An Pharmaceuticals agree to reorganize with the other party based on the principles of equality, free-will and mutual benefit. The Agreement shall be construed in accordance with the laws of People’s Republic of China. Zongyu Lu is the legal representative of Ze An Pharmaceuticals and has been fully authorized to sign this agreement by all the shareholders of Ze An Pharmaceuticals.

 

2.  

Yangling and Ze An Pharmaceuticals has acknowledged and confirmed that Shareholders of Ze An Pharmaceuticals invested totally eight million Ren Min Bi (RMB) to Ze An Pharmaceuticals as its capitals.

 

3.  

Yangling shall invest 1,440,000 RMB in cash to purchase 18% of shares of Ze An Pharmaceuticals held by Weiliang Wu. Yangling shall invest 1,960,000 RMB in cash and 120,900 shares of common stocks of Worldwide Biotech & Pharmaceutical Company (WWBP) which is worth of 1,000,000 RMB (the share price of the WWBP’s common stocks is $1 per share, the exchange rate for RMB is $1 US for 8.27 RMB based on the foreign exchange rate on December 31, 2004) agreed by both Yangling and Ze An Pharmaceuticals to purchase 37% of shares of Ze An Pharmaceuticals held by Zhon


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more